We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ADVANTECH SERVICE-IOT CO., LTD. TAIWAN BRAN

Download Mobile App





Mediplus Launches IV Drug Delivery System at Arab Health Show

By HospiMedica International staff writers
Posted on 30 Jan 2017
Print article
Image: The Argentum infusion delivery set is designed to facilitate the administration of intravenous medicines in one complete system (Photo courtesy of Mediplus).
Image: The Argentum infusion delivery set is designed to facilitate the administration of intravenous medicines in one complete system (Photo courtesy of Mediplus).
UK medical devices manufacturer Mediplus Ltd. launched a pioneering IV administration set at Arab Health 2017 that allows clinicians to access a variety of pumps and deliver fluids in a safe manner.

Mediplus develops, manufactures and markets patient centric products for the healthcare sector that focus on two key clinical areas - pelvic floor, which includes urology, urogynecology, gynecology, gastroenterology, and critical care which covers anesthetics and general surgery sectors.

At the four-day event held from January 30 to February 2, 2017, in Dubai, United Arab Emirates, Mediplus launched the new Argentum, a dedicated infusion delivery set designed to facilitate the administration of intravenous medicines in one complete system. The system offers convenience to the end user while maintaining safe, cost effective drug delivery standards. The IV administration set has been developed to facilitate the administration intravenous drugs within general surgery, obstetrics, coronary care, intensive and critical care and recovery. Additionally, Mediplus also showcased its extensive portfolio, which included a range of Gold Standard TIVA (Total Intravenous Anesthesia) solutions.

Emma Gray, Managing Director of Mediplus, said, “The Middle East is of strategic importance to Mediplus as it enables us to offer our leading products to the region and achieve our goals of enabling clinicians to deliver world class, leading care to patients. Qatar has recently benefitted from Mediplus’ Gold Standard TIVA solutions and we are keen to continue this growth throughout the Middle Eastern market.”


Print article
Radcal

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.